Arthur Tzianabos Homology Medicines, Inc. (FIXX) insider trading activity

Arthur Tzianabos is of Homology Medicines, Inc.. Currently has a direct ownership of 128,778 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Jan 09, 2024, when has been sold 13,037 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $7,431. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K

0% 3M change

18.8% 12M change

Total Value Held $0

ARTHUR TZIANABOS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 09 2024	SELL Open market or private sale	$7,431 $0.57 p/Share	13,037 Reduced 9.19%	128,778 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	33,420 Added 19.07%	141,815 Common Stock
Jan 09 2023	SELL Open market or private sale	$14,756 $1.39 p/Share	10,616 Reduced 8.92%	108,395 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	33,000 Added 21.71%	119,011 Common Stock
Jan 05 2022	SELL Open market or private sale	$20,238 $3.78 p/Share	5,354 Reduced 5.86%	86,011 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	13,860 Added 13.17%	91,365 Common Stock

Also insider at

STOK

Stoke Therapeutics, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

Director